{{Rsnum
|rsid=9837561
|Chromosome=3
|position=3608555
|Orientation=plus
|GMAF=0.1116
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 81.4 | 16.8 | 1.8
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 41.1 | 46.6 | 12.3
| ASW | 56.1 | 35.1 | 8.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 98.2 | 1.8 | 0.0
| GIH | 95.0 | 5.0 | 0.0
| LWK | 30.6 | 54.6 | 14.8
| MEX | 86.2 | 13.8 | 0.0
| MKK | 53.4 | 43.2 | 3.4
| TSI | 88.2 | 11.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=3E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}